XML 46 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation
6 Months Ended
Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation

Note 5. Stock-Based Compensation

We currently grant stock-based compensation under two equity incentive plans (2006 and 2013 Equity Incentive Plans) approved by the Company’s stockholders and one plan adopted in 2012 pursuant to NASDAQ Listing Rule 5635(c)(4) concerning inducement grants for new employees (our “2012 Commencement Incentive Plan”). As of June 30, 2015, we had 5,295,655 shares available to grant under the above mentioned plans. At our annual stockholders meeting held on June 12, 2007, our stockholders approved an amendment to our 2006 Equity Incentive Plan to provide for an annual increase in the number of shares of common stock available for issuance under the plan each January 1 (beginning January 1, 2008) equal to 4% of the outstanding common shares as of that date. The amendment further provided an aggregate limit of 3,000,000 shares issuable pursuant to incentive stock option awards under the plan. At our annual stockholders meeting held on December 20, 2013, our stockholders approved our 2013 Equity Incentive Plan to grant stock-based compensation of up to an initial 6,000,000 shares, plus an increase of 4% per year of the outstanding number of shares of our common stock beginning in January 1, 2015. Under the three stockholder-approved plans we may grant incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, 401(k) Plan employer match in form of shares and performance-based shares to our employees, directors and consultants, at prices determined by our Board of Directors. Incentive stock options may only be granted to employees under these plans with a grant price not less than the fair market value on the date of grant. Under our 2012 Commencement Inducement Plan, we may only award options, restricted stock units and other equity awards to newly hired employees and newly engaged directors, in each case as allowed by NASDAQ listing requirements.

Generally, stock options and restricted stock units granted to employees have a maximum term of ten years. Stock based awards may vest over a period of time from the date of grant or upon the attainment of certain performance goals established by the Compensation Committee or the Single Member Committee established under our 2006 Equity Incentive Plan and our 2013 Equity Incentive Plan. Upon employee termination of service, any unexercised vested option will be forfeited three months following termination or the expiration of the option, whichever is earlier.

 

Our stock-based compensation expense for the three and six months ended June 30 was as follows:

 

     Three months ended     Six months ended  
   June 30,     June 30,  
     2015     2014     2015     2014  

Research and development expense

   $ 698,039      $ 39,596      $ 1,281,708      $ 225,889   

General and administrative expense

     653,535        474,064        1,378,760        808,877   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total stock-based compensation

   $ 1,351,574      $ 513,660      $ 2,660,468      $ 1,034,766   
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect on basic and diluted net loss per share

   $ (0.01   $ (0.01   $ (0.03   $ (0.02

As of June 30, 2015, we had approximately $9,636,000 of total unrecognized compensation expense related to unvested awards of stock options and restricted stock units granted under our various equity incentive plans that we expect to recognize over a weighted-average vesting period of 2.1 years.

Stock Options

A summary of our stock option activity for the three months ended June 30, 2015 is as follows:

 

     Number of options      Weighted-average
exercise price ($) per share
 

Outstanding options at March 31, 2015

     276,229         18.66   

Granted (1)

     2,490,000         0.70   

Exercised

     —           —    

Cancelled

     (1,000      32.40   
  

 

 

    

Outstanding options at June 30, 2015

     2,765,229         2.49   
  

 

 

    

A summary of changes in unvested options for the three months ended June 30, 2015 is as follows:

 

     Number of options      Weighted-average exercise
price ($) per share
     Weighted-average grant date
fair value ($) per option
 

Unvested options at March 31, 2015

     —          —          —    

Granted

     2,490,000         0.70         0.46   

Vested

     —          —          —    

Cancelled

     —           —           —     
  

 

 

    

 

 

    

 

 

 

Unvested options at June 30, 2015

     2,490,000         0.70         0.46   

Restricted Stock Units

We have granted restricted stock units (RSUs) to certain employees and members of the Board of Directors which entitle the holders to receive shares of our common stock upon vesting of the RSUs. The fair value of restricted stock units granted is based upon the market price of the underlying common stock as if it were vested and issued on the date of grant.

A summary of changes in our restricted stock units for the three months ended June 30, 2015 is as follows:

 

     Number of RSUs      Weighted Average
Grant Date
Fair Value ($)
 

Outstanding at March 31, 2015

     9,984,518         1.25   

Granted (1)

     150,000         0.71   

Vested and exercised

     (597,500      1.70   

Cancelled

     (178,500      1.27   
  

 

 

    

Outstanding at June 30, 2015

     9,358,518         1.22   
  

 

 

    

 

(1) These stock awards are performance based and vest on achievement of predefined milestones.

 

Stock Appreciation Rights

In July 2006, we granted cash-settled Stock Appreciation Rights (SARs) to certain employees that give the holder the right, upon exercise, to the difference between the price per share of our common stock at the time of exercise and the exercise price of the SARs.

The SARs have a maximum term of ten years with an exercise price of $20.00, which is equal to the market price of our common stock at the date of grant. The SARs vest 25% on the first anniversary of the grant date and 75% vest monthly over the remaining three-year service period. At June 30, 2015 and 2014, there were 110,593 SARs outstanding. All of the outstanding SARs as of June 30, 2015 are fully vested. There were no SARs granted, exercised or forfeited during the three months ended June 30, 2015. Compensation expense is based on the fair value of SARs which is calculated using the Black-Scholes option pricing model.

The stock-based compensation expense and liability are re-measured at each reporting date through the earlier of date of settlement or forfeiture of the SARs. For the three months ended June 30, 2015 and 2014, the re-measured liability and expense for the respective periods related to the SARs were not significant.

The compensation expense related to the SARs recognized for the three months ended June 30, 2015 may not be representative of compensation expense for future periods and its resulting effect on net loss and net loss per share attributable to common stockholders, due to changes in the fair value calculation which is dependent on the stock price, volatility, interest and forfeiture rates, additional grants and subsequent periods of vesting. We will continue to recognize compensation cost each period, which will be the change in fair value from the previous period through the earlier date of settlement or forfeiture of the SARs.